Quanterix Corp
QTRX6.800USD
+0.210+3.19%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
317.44MMarket Cap
LossP/E TTM
More Details of Quanterix Corp Company
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Quanterix Corp Info
Ticker SymbolQTRX
Company nameQuanterix Corp
IPO dateDec 07, 2017
CEOToloue (Masoud)
Number of employees471
Security typeOrdinary Share
Fiscal year-endDec 07
Address900 Middlesex Turnpike
CityBILLERICA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01821
Phone16173019400
Websitehttps://www.quanterix.com/
Ticker SymbolQTRX
IPO dateDec 07, 2017
CEOToloue (Masoud)
Company Executives of Quanterix Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
285.62K
-0.52%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
138.14K
+3.81%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
--
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
14.84K
-1.52%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
6.27K
+49.75%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
5.02K
+70.88%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
3.96K
-79.63%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
285.62K
-0.52%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
138.14K
+3.81%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
--
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
14.84K
-1.52%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
6.27K
+49.75%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
5.02K
+70.88%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Product revenue
16.83M
68.83%
Service and other revenue
7.09M
28.99%
Collaboration and license revenue
532.00K
2.18%
By RegionUSD
Name
Revenue
Proportion
North America
14.67M
60.01%
EMEA
6.51M
26.61%
Asia Pacific
3.27M
13.38%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product revenue
16.83M
68.83%
Service and other revenue
7.09M
28.99%
Collaboration and license revenue
532.00K
2.18%
Shareholding Stats
Updated: Fri, Nov 21
Updated: Fri, Nov 21
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Portolan Capital Management, L.L.C.
9.12%
Columbia Threadneedle Investments (UK)
6.71%
BlackRock Institutional Trust Company, N.A.
6.12%
The Vanguard Group, Inc.
5.67%
Telegraph Hill Partners
5.36%
Other
67.01%
Shareholders
Shareholders
Proportion
Portolan Capital Management, L.L.C.
9.12%
Columbia Threadneedle Investments (UK)
6.71%
BlackRock Institutional Trust Company, N.A.
6.12%
The Vanguard Group, Inc.
5.67%
Telegraph Hill Partners
5.36%
Other
67.01%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
36.88%
Investment Advisor
22.56%
Hedge Fund
12.00%
Individual Investor
5.94%
Private Equity
5.36%
Research Firm
4.36%
Pension Fund
0.44%
Bank and Trust
0.20%
Family Office
0.13%
Other
12.12%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
384
34.11M
73.41%
-9.53M
2025Q2
391
36.46M
81.18%
-12.95M
2025Q1
401
40.45M
104.19%
-6.42M
2024Q4
388
38.02M
98.63%
-6.28M
2024Q3
386
36.47M
95.03%
-5.94M
2024Q2
394
35.66M
93.20%
-9.57M
2024Q1
395
35.56M
93.43%
-9.17M
2023Q4
388
34.77M
91.99%
-10.35M
2023Q3
382
36.53M
97.35%
-9.84M
2023Q2
388
36.74M
98.24%
-9.95M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Portolan Capital Management, L.L.C.
3.63M
7.82%
+670.23K
+22.62%
Jun 30, 2025
Columbia Threadneedle Investments (UK)
3.13M
6.73%
+128.33K
+4.28%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.65M
5.7%
-36.11K
-1.35%
Jun 30, 2025
The Vanguard Group, Inc.
2.53M
5.44%
+3.27K
+0.13%
Jun 30, 2025
Walt (David R)
1.86M
4.01%
+2.15K
+0.12%
Jul 31, 2025
Invenomic Capital Management LP
1.14M
2.46%
+242.86K
+26.92%
Jun 30, 2025
William Blair Investment Management, LLC
1.13M
2.43%
+21.92K
+1.98%
Jun 30, 2025
Easterly Investment Partners LLC
1.08M
2.33%
-241.99K
-18.25%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.63%
iShares Micro-Cap ETF
0.04%
Fidelity Enhanced Small Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.03%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Biotechnology ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Value ETF
0.01%
Global X Russell 2000 ETF
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.63%
iShares Micro-Cap ETF
Proportion0.04%
Fidelity Enhanced Small Cap ETF
Proportion0.03%
Avantis US Small Cap Equity ETF
Proportion0.03%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
iShares Biotechnology ETF
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Quanterix Corp?
The top five shareholders of Quanterix Corp are:
Portolan Capital Management, L.L.C. holds 3.63M shares, accounting for 7.82% of the total shares.
Columbia Threadneedle Investments (UK) holds 3.13M shares, accounting for 6.73% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.65M shares, accounting for 5.70% of the total shares.
The Vanguard Group, Inc. holds 2.53M shares, accounting for 5.44% of the total shares.
Walt (David R) holds 1.86M shares, accounting for 4.01% of the total shares.
Portolan Capital Management, L.L.C. holds 3.63M shares, accounting for 7.82% of the total shares.
Columbia Threadneedle Investments (UK) holds 3.13M shares, accounting for 6.73% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.65M shares, accounting for 5.70% of the total shares.
The Vanguard Group, Inc. holds 2.53M shares, accounting for 5.44% of the total shares.
Walt (David R) holds 1.86M shares, accounting for 4.01% of the total shares.
What are the top three shareholder types of Quanterix Corp?
The top three shareholder types of Quanterix Corp are:
Portolan Capital Management, L.L.C.
Columbia Threadneedle Investments (UK)
BlackRock Institutional Trust Company, N.A.
Portolan Capital Management, L.L.C.
Columbia Threadneedle Investments (UK)
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Quanterix Corp (QTRX)?
As of 2025Q3, 384 institutions hold shares of Quanterix Corp, with a combined market value of approximately 34.11M, accounting for 73.41% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -7.78%.
What is the biggest source of revenue for Quanterix Corp?
In FY2025Q2, the Product revenue business generated the highest revenue for Quanterix Corp, amounting to 16.83M and accounting for 68.83% of total revenue.
